Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer

Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78

(2015) L. Mo et al.   MOLECULAR CANCER THERAPEUTICS

Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles

(2015) Angelica Loskog   Viruses-Basel

Going viral: a review of replication-selective oncolytic adenoviruses

(2015) Christopher Larson et al.   Oncotarget

The Effect of Bevacizumab on Human Malignant Melanoma Cells with Functional VEGF/VEGFR2 Autocrine and Intracrine Signaling Loops

(2015) Una Adamcic et al.   NEOPLASIA

Tumor cell response to bevacizumab single agent therapy in vitro

(2013) Melanie Hein et al.   Cancer Cell International

Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers

(2013) I-K Choi et al.   CANCER GENE THERAPY

The ING tumor suppressor genes: Status in human tumors

(2013) Claire Guérillon et al.   CANCER LETTERS

A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer

(2013) Kenneth H. Kim et al.   GYNECOLOGIC ONCOLOGY

Radiosensitivity by ING4–IL-24 bicistronic adenovirus-mediated gene cotransfer on human breast cancer cells

(2012) Y Zhao et al.   CANCER GENE THERAPY

Synergistic Tumor Suppression by Adenovirus-Mediated Inhibitor of Growth 4 and Interleukin-24 Gene Cotransfer in Hepatocarcinoma Cells

(2011) Yufeng Xie et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells

(2011) Y Zhu et al.   CANCER GENE THERAPY

Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells

(2011) Belal Azab et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Tumor-Suppressive Effect of Adenovirus-Mediated Inhibitor of Growth 4 Gene Transfer in Breast Carcinoma Cells In Vitro and In Vivo

(2010) Zhengyi Li et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells

(2010) R Dash et al.   CANCER GENE THERAPY

A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases

(2010) K. J. Kimball et al.   CLINICAL CANCER RESEARCH

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14

(2010) Hongjie Wang et al.   NATURE MEDICINE

Adenovirus-Mediated ING4 Expression Suppresses Pancreatic Carcinoma Cell Growth via Induction of Cell-Cycle Alteration, Apoptosis, and Inhibition of Tumor Angiogenesis

(2009) Yu Feng Xie et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Oncolytic viruses from the perspective of the immune system

(2009) Ramon Alemany et al.   Future Microbiology

Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation

(2009) Fang Zhou   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Cisplatin Enhances Protein Kinase R-Like Endoplasmic Reticulum Kinase- and CD95-Dependent Melanoma Differentiation-Associated Gene-7/Interleukin-24-Induced Killing in Ovarian Carcinoma Cells

(2009) A. Yacoub et al.   MOLECULAR PHARMACOLOGY

Eradication of Therapy-resistant Human Prostate Tumors Using an Ultrasound-guided Site-specific Cancer Terminator Virus Delivery Approach

(2009) Adelaide Greco et al.   MOLECULAR THERAPY

A cancer terminator virus eradicates both primary and distant human melanomas

(2008) D Sarkar et al.   CANCER GENE THERAPY

Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis

(2008) Yufeng Xie et al.   CANCER LETTERS

A Fiber-Modified Mesothelin Promoter-Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer

(2008) Y. Tsuruta et al.   CLINICAL CANCER RESEARCH